Hypersensitivity reactions to oxaliplatin: experience in a single institute.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Annals of Oncology

• Publication date

  2006-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ANNONC/MDJ042PMID 16282245
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypersensitivity and idiosyncratic reactions to oxaliplatin

  2004cited by this paper
• Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol.

  2004cited by this paper
• Hypersensitivity Reactions to oxaliplatin: incidence and management.

  2004cited by this paper
• Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

  2004cited by this paper
• Oxaliplatin/Fluorouracil/Leucovorin in Advanced Colorectal Carcinoma: An Asian Experience

  2003cited by this paper
• Hypersensitivity reactions related to oxaliplatin (OHP)

  2003cited by this paper
• Hypersensitivity and idiosyncratic reactions to oxaliplatin

  2003cited by this paper
• Adverse reactions to oxaliplatin: a retrospective study of 25 patients treated in one institution

  2003cited by this paper
• Clinical features of hypersensitivity reactions to carboplatin.

  1999cited by this paper
• Hypersensitivity and cross-reactivity to cisplatin and analogues

  1995cited by this paper

• Oxaliplatin‐Induced Hypersensitivity Reactions Resulting in Respiratory and Cardiac Arrest: A Rare Case

  2025cites this paper
• Misdiagnosis of severe and atypical oxaliplatin‑related hypersensitivity reaction following chemotherapy combined with PD‑1 inhibitor: A case report and literature review

  2024cites this paper
• Cytokine profiling, pretreatment with anakinra, and tolerance development in platinum-induced mixed hypersensitivity reactions.

  2023cites this paper
• Allergy in Cancer Care: Antineoplastic Therapy-Induced Hypersensitivity Reactions

  2023cites this paper
• Leucovorin-induced Hypersensitivity Reaction in a Patient with Metastatic Colorectal Cancer Treated with Cetuximab Plus FOLFOX Chemotherapy: A Case Report

  2023cites this paper
• Simplified Graded Infusion Strategy for Mitigation of Oxaliplatin Hypersensitivity.

  2022cites this paper
• Risk factors for oxaliplatin-induced hypersensitivity reaction in patients with colorectal cancer.

  2022cites this paper
• Oxaliplatin-Related Hypersensitivity Reactions: A Single Institution Series and Literature Review

  2022cites this paper
• Incidence of oxaliplatin hypersensitivity reaction among colorectal cancer patients: A 5-year retrospective study

  2022cites this paper
• Oxaliplatin Induced Severe Hypoxemia, Chills and Hypersensitivity Reaction

  2022cites this paper
• Hypersensitivity Reactions to Platinum Agents and Taxanes

  2021cites this paper
• PLATINUM HYPERSENSITIVITY REACTIONS, A FOCUS ON DESENSITISATION

  2021cites this paper
• Incidence of hypersensitivity reactions in patients on H1-receptor antagonists receiving oxaliplatin-based chemotherapy

  2021cites this paper
• Safety Profile of Oxaliplatin in 3,687 Patients With Cancer in China: A Post-Marketing Surveillance Study

  2021cites this paper
• Clinical Features of Oxaliplatin-induced Hypersensitivity Reactions in Chinese Patients: A Retrospective Multicenter Analysis

  2021cites this paper
• Desensitization for hypersensitivity reactions related to chemotherapy

  2020cites this paper
• Oxaliplatin-induced Immune Thrombocytopenia: A Case Report and Literature Review.

  2020cites this paper
• Allergy evaluation of hypersensitivity to platinium salts and taxanes: a six-year experience.

  2020cites this paper
• Breakthrough reactions during rapid drug desensitization: Clinical outcome and risk factors.

  2019cites this paper
• Retrospective evaluation of a rechallenge protocol in patients experiencing hypersensitivity reactions with prior chemotherapy in a tertiary hospital

  2018cites this paper
• Clinical Analysis of Hypersensitivity Reactions to Oxaliplatin Among Colorectal Cancer Patients

  2018cites this paper
• Basophil Activation Test is a Relevant Biomarker of the Outcome of Rapid Desensitization in Platinum Compounds-Allergy.

  2017cites this paper
• Atypical presentation of fever as hypersensitivity reaction to oxaliplatin

  2016cites this paper
• Prognostic Value of the Cell Cycle Progression Score in Patients with Prostate Cancer: A Systematic Review and Meta-analysis.

  2016cites this paper
• Utility of rotational thromboelastometry for the diagnosis of asymptomatic hyperfibrinolysis secondary to anaphylaxis.

  2016cites this paper
• Managing Infusion-Related Reactions for Patients With Chronic Lymphocytic Leukemia Receiving Obinutuzumab.

  2016cites this paper
• Chemotherapy‐mediated pain and peripheral neuropathy: impact of oxidative stress and inflammation

  2016cites this paper
• A New Practical Desensitization Protocol for Oxaliplatin-Induced Immediate Hypersensitivity Reactions: A Necessary and Useful Approach.

  2016cites this paper
• Commercialized biomarkers: new horizons in prostate cancer diagnostics

  2015cites this paper
• Hypersensitivity Reactions to Oxaliplatin: Identifying the Risk Factors and Judging the Efficacy of a Desensitization Protocol.

  2015cites this paper
• A single-arm Phase II validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: the AVOID trial

  2015cites this paper
• Platinum hypersensitivity and desensitization.

  2015cites this paper
• Presentation and Diagnosis of Hypersensitivity to Platinum Drugs

  2015cites this paper
• Oxaliplatin-related acute disseminated intravascular coagulation syndrome in a patient with metastatic colon cancer.

  2015cites this paper
• Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy.

  2015cites this paper
• Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.

  2014cites this paper
• Overcoming oxaliplatin hypersensitivity: different strategies are needed according to the severity and previous exposure

  2014cites this paper
• Infrared imaging in breast cancer: automated tissue component recognition and spectral characterization of breast cancer cells as well as the tumor microenvironment.

  2014cites this paper
• A Case of Oxaliplatin-Related Ocular Toxicity

  2014cites this paper
• Diagnostic Tools for Hypersensitivity to Platinum Drugs and Taxanes: Skin Testing, Specific IgE, and Mast Cell/Basophil Mediators

  2014cites this paper
• Serum Lactate Dehydrogenase Levels as a Predictive Marker of Oxaliplatin-Induced Hypersensitivity Reactions in Japanese Patients with Advanced Colorectal Cancer

  2014cites this paper
• Hypersensitivity to oxaliplatin: clinical features and risk factors

  2014cites this paper
• A 39-year-old female patient with metastatic rectal cancer develops thrombocytopenia.

  2014cites this paper
• Hypersensitivity reactions associated with oxaliplatin and their clinical management

  2014influential citation
• Salvage chemotherapy with gemcitabine plus oxaliplatin for patients with testicular germ cell cancer

  2014cites this paper
• Acute infusion reactions to chemotherapeutic drugs: a single institute experience.

  2013cites this paper
• Clinical Outcomes of Reintroducing Oxaliplatin to Patients with Colorectal Cancer after Mild Hypersensitivity Reactions

  2013cites this paper
• Prognostic significance and diagnostic value of PTEN and p53 expression in endometrial carcinoma. A retrospective clinicopathological and immunohistochemical study.

  2013cites this paper
• Effectiveness of oxaliplatin desensitization protocols

  2013cites this paper
• The continued evidence from overviews: what is the clinical utility?

  2013cites this paper
• Updates on desensitization for hypersensitivity reactions related to chemotherapy

  2013cites this paper
• Updates on desensitization for hypersensitivity reactions related to chemotherapy

  2013cites this paper
• Dexamethasone as a means for controlling vascular pain caused by the administration of oxaliplatin via the peripheral vein and also for controlling oxaliplatin-induced hypersensitivity reactions.

  2012cites this paper
• Successful rechallenge for oxaliplatin hypersensitivity reactions in patients with metastatic colorectal cancer.

  2012cites this paper
• Revisión de las reacciones de hipersensibilidad a antineoplásicos

  2012cites this paper
• Review of hypersensitivity reactions to antineoplastic agents.

  2012cites this paper
• Oxaliplatin induced disseminated intravascular coagulation: A case report and review of literature.

  2012cites this paper
• Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis.

  2012cites this paper
• Hypersensitivity reactions to oxaliplatin: clinical features and risk factors in Koreans.

  2012influential citation
• Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity

  2011cites this paper
• A Retrospective Review of the Frequency and Nature of Acute Hypersensitivity Reactions at a Medium-Sized Infusion Center: Comparison to Reported Values and Inconsistencies Found in Literature

  2011cites this paper
• A 67-Year-Old Woman with BRCA 1 Mutation Associated with Pancreatic Adenocarcinoma

  2011cites this paper
• Risk Factors for Oxaliplatin-Induced Hypersensitivity Reactions in Japanese Patients with Advanced Colorectal Cancer

  2011influential citation
• Platinum Agent-Induced Hypersensitivity Reactions: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS

  2011cites this paper
• High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin

  2011cites this paper
• Oxaliplatin-induced acute thrombocytopenia

  2011cites this paper
• Re-challenging patients with oxaliplatin allergy: the successful use of a standardised pre-medication protocol in a single institute.

  2011cites this paper
• Clinical features of hypersensitivity reactions to oxaliplatin among Chinese patients with colorectal cancer

  2010cites this paper
• Delayed urticaria with oxaliplatin

  2010cites this paper
• Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions.

  2010cites this paper
• Oxaliplatin-Free Interval as a Risk Factor for Hypersensitivity Reaction among Colorectal Cancer Patients Treated with FOLFOX

  2010cites this paper
• Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature

  2010cites this paper
• Overview of hypersensitivity to cancer therapies

  2010cites this paper
• Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity

  2010cites this paper
• Hypersensitivity Reactions Associated with Platinum Antineoplastic Agents: A Systematic Review

  2010cites this paper
• Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol.

  2009cites this paper
• Allergic reactions to oxaliplatin in a single institute in Japan.

  2009cites this paper
• Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol.

  2009cites this paper
• Variant hypersensitivity reaction (HSR) presented with persistent dry cough after receiving oxaliplatin in a pancreatic cancer patient.

  2009cites this paper
• [Therapeutic use and profile of toxicity of the FOLFOX4 regimen].

  2009cites this paper
• Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan

  2009influential citation
• Hypersensitivity to Oxaliplatin: An Investigation of Incidence and Risk Factors, and Literature Review

  2009cites this paper
• Managing toxicities associated with colorectal cancer chemotherapy and targeted therapy: a new guide for nurses.

  2009cites this paper
• Uso terapéutico y perfil de toxicidad del esquema FOLFOX4

  2009cites this paper
• A anaphylactic reaction to oxaliplatin

  2008cites this paper
• Fatal thrombocytopenia after oxaliplatin-based chemotherapy.

  2008cites this paper
• Hypersensitivity reactions to oxaliplatin and other antineoplastic agents

  2008influential citation
• Managing premedications and the risk for reactions to infusional monoclonal antibody therapy.

  2008cites this paper
• [Platinum salts hypersensitivity].

  2008cites this paper
• Clinical Features of Hypersensitivity Reactions to Oxaliplatin: A 10-Year Experience

  2008cites this paper
• Hypersensibilité aux sels de platine

  2008cites this paper
• Rechallenge with cisplatin in a patient with pancreatic cancer who developed a hypersensitivity reaction to oxaliplatin. Is skin test useful in this setting?

  2008cites this paper
• Standardization of Skin Tests for Diagnosis and Prevention of Hypersensitivity Reactions to Oxaliplatin

  2007cites this paper
• Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report.

  2007cites this paper
• Fever as the only manifestation of hypersensitivity reactions associated with oxaliplatin in a patient with colorectal cancer Oxaliplatin-induced hypersensitivity reaction.

  2007cites this paper
• Oxaliplatin-induced hypersensitivity reaction displaying marked elevation of immunoglobulin E

  2007cites this paper
• Preliminary experience with a modified premedication protocol that included intravenous diphenhydramine and calcium bromide for the prophylaxis of paclitaxel-related hypersensitivity reactions

  2007cites this paper
• Feasibility of oxaliplatin and infusional fluorouracil/leucovorin (FOLFOX4) for Japanese patients with unresectable metastatic colorectal cancer.

  2007cites this paper
• Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication

  2006cites this paper
• Serious delayed hypersensitivity reaction to oxaliplatin.

  2006cites this paper